INS and Hypoglycemia: The majority of patients who experienced hypoglycemia were also receiving insulin at doses exceeding 0.4 units/kg/day and sulfonylureas, which likely contributed to the incidence of hypoglycemia observed during the study, while 63 patients (47%) did not experience any adverse effects.